Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Leineweber CG, Rabehl M, Pietzner A, Rohwer N, Rothe M, Pech M, Sangro B, Sharma R, Verslype C, Basu B, Sengel C, Ricke J, Schebb NH, Weylandt KH, Benckert J.
Leineweber CG, et al. Among authors: weylandt kh.
Front Pharmacol. 2023 Mar 3;14:1124214. doi: 10.3389/fphar.2023.1124214. eCollection 2023.
Front Pharmacol. 2023.
PMID: 36937889
Free PMC article.